Icaridin API Manufacturers

Looking for Icaridin API 119515-38-7?

Description:

Here you will find a list of producers, manufacturers and distributors of Icaridin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Icaridin 

Synonyms:

KBR 3023 , Picaridin  

Cas Number:

119515-38-7 

Unique Ingredient Identifier:

N51GQX0837

Icaridin is a type of Insect repellents

Insect repellents are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that serve as effective tools in protecting humans from pesky and potentially harmful insect bites. These repellents are specifically formulated to deter insects such as mosquitoes, ticks, and flies, reducing the risk of diseases they carry, such as malaria, dengue fever, or Lyme disease.

APIs used in insect repellents typically include synthetic or natural compounds that exhibit repellent properties. Commonly employed synthetic active ingredients include DEET (N,N-diethyl-meta-toluamide), picaridin, and IR3535 (3-[N-acetyl-N-butyl]-aminopropionic acid ethyl ester). These ingredients act by either interfering with an insect's olfactory system or creating a barrier on the skin that repels the insects.

In recent years, there has been a growing demand for natural-based insect repellents due to concerns over potential side effects associated with synthetic chemicals. Natural repellents often feature active ingredients like citronella, lemon eucalyptus oil, or soybean oil. These natural alternatives provide a more environmentally friendly and potentially safer option for consumers.

Insect repellent APIs are available in various formulations, including lotions, sprays, creams, and wearable devices. Manufacturers carefully select the appropriate API concentration to ensure efficacy while minimizing the risk of adverse effects on the skin.

When considering insect repellents, it is essential to follow usage instructions and apply them to exposed skin or clothing as directed. Additionally, regular reapplication may be necessary, particularly in areas with high insect populations or during prolonged outdoor activities.

In conclusion, insect repellent APIs are a crucial subcategory of pharmaceutical ingredients that offer protection against insects and the diseases they may transmit. Whether synthetic or natural-based, these repellents play a vital role in safeguarding human health and promoting outdoor activities.

Icaridin (Insect repellents), classified under Others

The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.